DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	TBX1; COL2A1; GBX2; PRRX1; FOXG1; DLX5; DLX6; SIX1;	GO:0042472~inner ear morphogenesis	8	57	14.0350877192982	0.0001041649310951	0.00517056987755077	0.238225197414511	0.243016784244886	0.229579508133617	0.238225197414511	0.0430829474438142
down	WT1; HOXA11; HOXD11; LHX1; SHH; SIX1; ADAMTS16;	GO:0001658~branching involved in ureteric bud morphogenesis	7	42	16.6666666666667	0.00010810329705091	0.0052016427437133	0.24712413705838	0.252204992019773	0.236530013947391	0.24712413705838	0.0433418571368485
down	NKX2-1; LHX1; DLX6; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	4	8	50	0.0001092501047758	0.0052016427437133	0.249636489412713	0.254880494441951	0.238602228830357	0.249636489412713	0.0433418571368485
up	HP; HPR; JCHAIN; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; APOA1; APOB; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; ADRB2; IGLC2; IGLC3; ADRB3; FOLR2; IGHV1-2; FCGR2B; SFTPD; HBA1; IGLV3-21; COLEC12; CLEC9A; FCGR1B; STAB1; CD207; MAPK8IP2;	GO:0006898~receptor-mediated endocytosis	54	160	33.75	0.00013724349940624	0.0619228434128192	0.7600544997118	0.761564178205268	0.759780012712987	0.7600544997118	0.569608345627333
down	SHOX2; SOX11; SHH; RBPMS2; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	5	18	27.7777777777778	0.00013730585247462	0.0064066910764659	0.313606567052039	0.320334553823295	0.281339691720502	0.313606567052039	0.0533827298485096
down	TBX1; RET; KITLG; GBX2; ISL1; SHH; ALX1;	GO:0001755~neural crest cell migration	7	44	15.9090909090909	0.00014012547198638	0.00641005345380857	0.319906452544918	0.326912726144237	0.285355728106208	0.319906452544918	0.0534107463205371
up	F2; JCHAIN; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; APOB; IGKV1-16; IGKV3-11; ATP1B1; IGKV2-30; IGKV4-1; IGHV4-34; CEACAM5; PROS1; CD48; IGLC2; IGLC3; PSG1; VPREB1; SELE; IGHV1-2; CEACAM8; CEACAM3; CEACAM6; ATP1B3; CXADR; IGLV3-21; AIMP1; GRB14; GRB7; ANGPT1; NKX2-3; FCAMR; FOXJ1; SIRPG; CD84; SLC7A11;	GO:0050900~leukocyte migration	62	193	32.1243523316062	0.00014507063693758	0.0619228434128192	0.803256116723398	0.804996964366649	0.80311104608646	0.803256116723398	0.569608345627333
down	TBX1; GLI2; HOXD12; LHX1; SHH; SIX1;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.00016405889274673	0.00736056532265628	0.374382393248043	0.382749396778127	0.318110193035914	0.374382393248043	0.0613307346119796
down	DLX2; DLX5; DLX1; OSR1; DLX6;	GO:0009790~embryo development	5	19	26.3157894736842	0.00017023098730473	0.00749337534682903	0.388296882042092	0.397148893381938	0.325992340688561	0.388296882042092	0.0624373529203964
down	HOXD8; HOXC8; TBX4; NKX3-2; TCF15; HHIP;	GO:0048705~skeletal system morphogenesis	6	33	18.1818181818182	0.00022159899178897	0.00957389718229029	0.50524570127886	0.516990447843676	0.385139047729236	0.50524570127886	0.0797729687259301
down	NPR1; NPPB; AZU1; HRH1;	GO:0043114~regulation of vascular permeability	4	11	36.3636363636364	0.00028544223144355	0.0121079404719603	0.650522845459863	0.665936725957815	0.44783849566891	0.650522845459863	0.100887479593138
down	NOTO; LHX1; SHH; NODAL; RIPPLY3;	GO:0009880~embryonic pattern specification	5	22	22.7272727272727	0.00030573688890089	0.0125137572246631	0.696468632916246	0.713284161805796	0.465080822467747	0.696162896027345	0.104268882850915
down	FOXE1; TBX1; NKX2-1; SHH; SIX1;	GO:0030878~thyroid gland development	5	22	22.7272727272727	0.00030573688890089	0.0125137572246631	0.696468632916246	0.713284161805796	0.465080822467747	0.696162896027345	0.104268882850915
up	ACKR2; CCR2; XCR1; CXCR3; CCR5; CCR6; CCR8; CX3CL1; FOXC1; GPR17; ACKR1; CCL23; CCL2; CCL16; CCL22; CCL21; CCL11; CCL13; CCL1; CCL14; TFF2; XCL2; CXCL13; CCL20; CXCL2; CCL8; CCL17; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	29	70	41.4285714285714	0.0003504027988902	0.138884652217267	1	1	0.999999999999998	0.999999999999998	1
down	SOX1; PITX3; SOX11; LCTL;	GO:0002089~lens morphogenesis in camera-type eye	4	12	33.3333333333333	0.00037381689397597	0.0150364623042405	0.850807250689321	0.872114813645951	0.51497799032324	0.850807250689321	0.125288919893942
down	HOXC13; LHX2; DSG4; ALX4; KRT84; EDAR;	GO:0001942~hair follicle development	6	37	16.2162162162162	0.0003836110265929	0.0151688902549362	0.872715085498849	0.894964525041237	0.521327385139752	0.872715085498849	0.126392354636152
down	ISL1; NKX3-2; MSLN; SHH; PROX1;	GO:0031016~pancreas development	5	24	20.8333333333333	0.00043330257306617	0.0165720475895637	0.984896748579414	1	0.546750950430696	0.984896748579414	0.138083938955634
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00048014527093176	0.0179257921673619	1	1	0.567762874473188	0.999643926518233	0.14936379937312
down	PIFO; NTRK2; RET; FLT4; ROS1; EPHA8; KIT; NTRK1;	GO:0033674~positive regulation of kinase activity	8	73	10.958904109589	0.00048406554073887	0.0179257921673619	1	1	0.569545300847137	0.999643926518233	0.14936379937312
up	ANXA1; CCL2; FOLR2; LGALS3; CCR2; CCL23; DEFB104A; CX3CL1; CCL20; CCL14; CCL18; CCL17; CCL21; CCL19; CCL16; CCL22; CCL13; CCL11; CCL1; XCL2; CCL8;	GO:0002548~monocyte chemotaxis	21	44	47.7272727272727	0.00053296378053657	0.184838501137342	1	1	0.999999999999998	0.999999999999998	1
down	CYP26A1; GLI2; WT1; SOX11; LHX1; SIX1; PROX1; HAS2; SIX2;	GO:0001822~kidney development	9	94	9.57446808510638	0.00054475442722978	0.0198580012301109	1	1	0.596848706703815	0.999643926518233	0.165463622694782
down	TBX1; GLI2; DLX1; DLX2; SHH; AMTN; EDAR;	GO:0042475~odontogenesis of dentin-containing tooth	7	57	12.280701754386	0.00058389183639051	0.0200534579822303	1	1	0.614323713777205	0.999643926518233	0.167092234855244
down	TBX1; CYP7B1; DLX5; DLX6; SFRP1; OSR1; NODAL;	GO:0050679~positive regulation of epithelial cell proliferation	7	57	12.280701754386	0.00058389183639051	0.0200534579822303	1	1	0.614323713777205	0.999643926518233	0.167092234855244
down	FOXE1; TBX1; SOX11;	GO:0060023~soft palate development	3	5	60	0.00058449856099085	0.0200534579822303	1	1	0.614759812617096	0.999643926518233	0.167092234855244
down	SHOX2; COL2A1; HOXA11;	GO:0060351~cartilage development involved in endochondral bone morphogenesis	3	5	60	0.00058449856099085	0.0200534579822303	1	1	0.614759812617096	0.999643926518233	0.167092234855244
down	GABRD; SLC26A4; GABRA1; CLDN17; ANO4; ANO1; ANO7; SLC26A10; SLC12A5;	GO:1902476~chloride transmembrane transport	9	97	9.27835051546392	0.00067152096765055	0.0227051944569382	1	1	0.653903844745757	0.999643926518233	0.189187405383875
down	WT1; MAB21L1; SHH; VAX1; PITX2; FOXC2;	GO:0043010~camera-type eye development	6	42	14.2857142857143	0.00070196327177063	0.0233954330434413	1	1	0.667567071453873	0.999643926518233	0.194938708131976
up	EVPLL; FOXN1; TGM5; SCEL; GJB5; KRT5; DSP; KRT15; FGF7; SPRR1B; SPRR2D; CRABP2; SPRR1A; SPRR2A; EMP1; ELF3; FABP5; KRT32; KRT31; CST6; ZNF750; GRHL2; CERS3; ACER1; GRHL3; EVPL; HOXB13; SPRR2F; GRHL1; CALML5; SPRR3;	GO:0008544~epidermis development	31	82	37.8048780487805	0.00077582128560616	0.253237194931093	1	1	0.999999999999998	0.999999999999998	1
up	IRF6; EREG; FOXN1; SCEL; CSTA; ANXA1; IVL; DSP; FLG; SPRR1B; TGM1; PAX6; SPRR1A; SPRR2A; AKR1C3; POU3F1; TGM3; CERS3; ACER1; EVPL; SPRR2F; TSG101; SPRR3;	GO:0030216~keratinocyte differentiation	23	53	43.3962264150943	0.00083566952350733	0.257618343663455	1	1	0.999999999999998	0.999999999999998	1
down	HOXD9; HOXD10; HOXA10; HOXA11; FOXL2; DEFB126; CCDC87;	GO:0007338~single fertilization	7	61	11.4754098360656	0.0008432031789447	0.0271785243827726	1	1	0.723650507455482	0.999643926518233	0.226460712322501
down	SOX1; GBX2; LHX6;	GO:0021884~forebrain neuron development	3	6	50	0.00086207064051657	0.0271785243827726	1	1	0.728449691236507	0.999643926518233	0.226460712322501
down	TH; PNMT; HDC;	GO:0042423~catecholamine biosynthetic process	3	6	50	0.00086207064051657	0.0271785243827726	1	1	0.728449691236507	0.999643926518233	0.226460712322501
down	TBX1; SHOX2; PAX7;	GO:0060415~muscle tissue morphogenesis	3	6	50	0.00086207064051657	0.0271785243827726	1	1	0.728449691236507	0.999643926518233	0.226460712322501
down	BCHE; TH; NTRK2; JPH3; SLC12A5; SLC24A2; NRXN1;	GO:0007612~learning	7	62	11.2903225806452	0.00092040242224655	0.0284349565074223	1	1	0.742747668900725	0.999643926518233	0.236929732270965
down	ISL1; SIX1; DMRTA2; ISL2;	GO:0048665~neuron fate specification	4	16	25	0.0009262994833108	0.0284349565074223	1	1	0.743957830294083	0.999643926518233	0.236929732270965
down	LCE2B; KRT34; CASP14; SPRR2B; BNC1; SPRR2G; EDAR; KLK5;	GO:0008544~epidermis development	8	82	9.75609756097561	0.00097743766199809	0.0296150917589812	1	1	0.756536750386524	0.999643926518233	0.246763020713744
down	TBX1; LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	5	30	16.6666666666667	0.0010595605591992	0.0312905668938195	1	1	0.776657889893015	0.999643926518233	0.260723649597431
down	KIT; LIF; PDX1; SHC4; OSR1;	GO:0048863~stem cell differentiation	5	30	16.6666666666667	0.0010595605591992	0.0312905668938195	1	1	0.776657889893015	0.999643926518233	0.260723649597431
down	PITX3; GLI2; LIF; EN2; EN1; ISL2;	GO:0048666~neuron development	6	47	12.7659574468085	0.0011941001896284	0.0340375401936448	1	1	0.808405828378427	0.999643926518233	0.283612365756121
down	RBP4; PAX7; DLX1; NKX3-2; SHH;	GO:0048706~embryonic skeletal system development	5	31	16.1290322580645	0.00120785880827967	0.0340375401936448	1	1	0.811681119163939	0.999643926518233	0.283612365756121
down	RBP4; LHX1; PROX1;	GO:0060059~embryonic retina morphogenesis in camera-type eye	3	7	42.8571428571429	0.00121093692073404	0.0340375401936448	1	1	0.812538673812541	0.999643926518233	0.283612365756121
down	LHX1; OSR1; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.00121093692073404	0.0340375401936448	1	1	0.812538673812541	0.999643926518233	0.283612365756121
down	MMP1; ELANE; MMP13; MMP16; CTRB2; TLL2; KLK5;	GO:0022617~extracellular matrix disassembly	7	66	10.6060606060606	0.00128646227235174	0.035372801411261	1	1	0.830085710756318	0.999643926518233	0.29473821652783
down	HOXB8; HOXD9; HOXD10; EN1; DMBX1; FOXA2;	GO:0008344~adult locomotory behavior	6	48	12.5	0.00131809048176179	0.035372801411261	1	1	0.837510541917693	0.999643926518233	0.29473821652783
down	LHX1; EN1; CDK5R2; FAIM2; PPARGC1A; GBX2;	GO:0021549~cerebellum development	6	48	12.5	0.00131809048176179	0.035372801411261	1	1	0.837510541917693	0.999643926518233	0.29473821652783
down	EFNA2; LHX2; DLX2; NR2E1;	GO:0021772~olfactory bulb development	4	18	22.2222222222222	0.00134941248418441	0.035372801411261	1	1	0.844596243734947	0.999643926518233	0.29473821652783
down	GLI2; EN2; SHH; GBX2;	GO:0030902~hindbrain development	4	18	22.2222222222222	0.00134941248418441	0.035372801411261	1	1	0.844596243734947	0.999643926518233	0.29473821652783
down	TBX1; RIPPLY3; ISL1; SIX1;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.00134941248418441	0.035372801411261	1	1	0.844596243734947	0.999643926518233	0.29473821652783
down	TBX1; UPK1B; WT1; DLX5; DLX6; SIX1; ACTL8;	GO:0030855~epithelial cell differentiation	7	68	10.2941176470588	0.00150771382695591	0.0390832928698683	1	1	0.870861366210019	0.999643926518233	0.325655293810929
down	TBX1; LIF; TCF15;	GO:0048644~muscle organ morphogenesis	3	8	37.5	0.00163722932344068	0.0415180001259468	1	1	0.88901552262829	0.999643926518233	0.345942103048365
down	WT1; SIX1; OSR1;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00163722932344068	0.0415180001259468	1	1	0.88901552262829	0.999643926518233	0.345942103048365
down	TBX1; TH; EN1; GAD1; NRXN1; NR2E1;	GO:0035176~social behavior	6	51	11.7647058823529	0.0017495017351552	0.0434211441289052	1	1	0.905002106658141	0.999643926518233	0.361799746402815
up	UGT1A9; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	8	9	88.8888888888889	0.0021016520113214	0.555336524324878	1	1	0.999999999999998	0.999999999999998	1
down	NPR1; NPPB; GUCA2B;	GO:0007589~body fluid secretion	3	9	33.3333333333333	0.0021465557296525	0.0516279847142194	1	1	0.96165696688432	0.999643926518233	0.430181934438216
down	ACTC1; PROX1; MYOM3;	GO:0030240~skeletal muscle thin filament assembly	3	9	33.3333333333333	0.0021465557296525	0.0516279847142194	1	1	0.96165696688432	0.999643926518233	0.430181934438216
down	RARB; FOXL2; VAX2;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.0021465557296525	0.0516279847142194	1	1	0.96165696688432	0.999643926518233	0.430181934438216
down	LHX2; PROX1; DISP3; NR2E1;	GO:2000179~positive regulation of neural precursor cell proliferation	4	22	18.1818181818182	0.00256799089557302	0.0605163915088067	1	1	0.986299834613192	0.999643926518233	0.504243164023965
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00261832159833686	0.66041211587142	1	1	0.999999999999998	0.999999999999998	1
down	BMPR1B; RET; LHX2; VAX2; NR2E1; RP1;	GO:0060041~retina development in camera-type eye	6	56	10.7142857142857	0.00269602698540639	0.0627628503935173	1	1	0.991168062305519	0.999643926518233	0.522961423781924
down	HOXC11; HOXA11; SIX1;	GO:0001759~organ induction	3	10	30	0.00274402517794203	0.0627628503935173	1	1	0.992805264859016	0.999643926518233	0.522961423781924
down	SHOX2; SIX2; SCIN;	GO:0032330~regulation of chondrocyte differentiation	3	10	30	0.00274402517794203	0.0627628503935173	1	1	0.992805264859016	0.999643926518233	0.522961423781924
up	PSMD12; PSMD14; CHUK; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; CALM1; FCER1A; IGHV1-2; TEC; PSMB2; PSMD7; LILRA4; PSMC6; RAC1; SKP1; IGLV3-21; MS4A2; PSMB7;	GO:0038095~Fc-epsilon receptor signaling pathway	50	171	29.2397660818713	0.00307171732058464	0.741085191822791	1	1	0.999999999999998	0.999999999999998	1
down	NKX2-8; CCK; CTNNA2; VAX2; NTNG1; ISL2; ISL1;	GO:0007409~axonogenesis	7	78	8.97435897435897	0.00309188469038491	0.0655760634787999	1	1	0.999643926518233	0.999643926518233	0.546402072370333
down	NTRK1; REG1A; TH; PROX1; FGF21;	GO:0031667~response to nutrient levels	5	40	12.5	0.00331466575599482	0.0696677045832064	1	1	0.999643926518233	0.999643926518233	0.580495018183803
down	ST8SIA3; ST8SIA6; B4GALNT1;	GO:0001574~ganglioside biosynthetic process	3	11	27.2727272727273	0.00343427208964564	0.0702820770626603	1	1	0.999643926518233	0.999643926518233	0.585614178715442
down	TBX1; LHX1; FOXC2;	GO:0048703~embryonic viscerocranium morphogenesis	3	11	27.2727272727273	0.00343427208964564	0.0702820770626603	1	1	0.999643926518233	0.999643926518233	0.585614178715442
down	COL2A1; SOX11; SHH;	GO:0060174~limb bud formation	3	11	27.2727272727273	0.00343427208964564	0.0702820770626603	1	1	0.999643926518233	0.999643926518233	0.585614178715442
down	ISL1; PROX1; FOXC2; PKP2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	4	25	16	0.0038678375717669	0.0784666526515841	1	1	0.999643926518233	0.999643926518233	0.65381084722552
down	FLT4; PROX1; FOXC2;	GO:0001946~lymphangiogenesis	3	12	25	0.00422147955420249	0.0834636593216475	1	1	0.999643926518233	0.999643926518233	0.695447606971761
down	LHX1; FAIM2; LHX5;	GO:0021702~cerebellar Purkinje cell differentiation	3	12	25	0.00422147955420249	0.0834636593216475	1	1	0.999643926518233	0.999643926518233	0.695447606971761
down	EMX2; ARX; LHX5;	GO:0021846~cell proliferation in forebrain	3	12	25	0.00422147955420249	0.0834636593216475	1	1	0.999643926518233	0.999643926518233	0.695447606971761
up	SH3KBP1; IGHG3; IGHG4; IGLC3; IGHV3-15; IGHV4-39; IGHV3-21; IGHD; IGHV4-59; IGHV3-73; IGHV3-23; IGHV1-2; TRBC1; IGHV1-18; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGHV5-51; IGHV1-3; IGHV4-34; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	32	98	32.6530612244898	0.0042836814981192	0.990422859710976	1	1	0.999999999999998	0.999999999999998	1
down	NOTO; GATA4; SHH; CCDC40; NODAL; TBX1;	GO:0001947~heart looping	6	63	9.52380952380952	0.00460652139420192	0.0842164319636306	1	1	0.999643926518233	0.999643926518233	0.70171996474658
up	COLEC12; IGHV3-11; IGHV4-39; IGHV3-74; IGHG2; IGHV3-30; IGHV1-2; TRDC; IGHV1-46; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV3-20; IGHV3-21; IGLC3; IGHV3-23; IGHG3; IGHV3-7; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV3-48; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	32	99	32.3232323232323	0.00484471317450208	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	OOEP; MPPED1; PRB2; CRYBA2; DIO3; RIPPLY3; EVX2; WT1-AS; ACTBL2; C5orf46; C6orf15; IGFL3; DCHS2; PTCHD4; KNDC1; ASCL5; KRT27; MAGEB6; ZNF114; KIF12; MPP4; POPDC3; KRT82; SPANXC; INSL5;	GO:0008150~biological_process	25	603	4.14593698175788	0.00486421275177196	0.0842164319636306	1	1	0.999643926518233	0.999643926518233	0.70171996474658
down	NKX2-1; DLX1; DLX2; CDK5R2; LHX5; HSD3B1;	GO:0021766~hippocampus development	6	64	9.375	0.00494434595911186	0.0842164319636306	1	1	0.999643926518233	0.999643926518233	0.70171996474658
down	GLI2; NKX2-1; ISL1; LHX3;	GO:0021983~pituitary gland development	4	27	14.8148148148148	0.00494541413588401	0.0842164319636306	1	1	0.999643926518233	0.999643926518233	0.70171996474658
down	TBX1; LHX1; POSTN; SFRP1;	GO:0044344~cellular response to fibroblast growth factor stimulus	4	27	14.8148148148148	0.00494541413588401	0.0842164319636306	1	1	0.999643926518233	0.999643926518233	0.70171996474658
down	BMPR1B; TBX4; EVX2;	GO:0035108~limb morphogenesis	3	13	23.0769230769231	0.00510940170655727	0.0863785085608559	1	1	0.999643926518233	0.999643926518233	0.719735122575156
down	ADAMTS3; COL2A1; LOX; FOXC2; LOXL4;	GO:0030199~collagen fibril organization	5	45	11.1111111111111	0.0052430717370866	0.0880006213138348	1	1	0.999643926518233	0.999643926518233	0.733251117937283
up	MS4A1; CD19; CTLA4; MNDA; TEC; NCKAP1L; IGHV4-34; IGHV3-33; IGHV3-11; IGHV3-21; IGHV4-39; IGHV1-2; IGHV2-5; IGLC3; IGHV3-30; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV3-73; IGHG4; IGHV1-46; IGHV4-59; IGHG3; IGHV1-18; TRBC1; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHD; IGHV3-15; IGHV3-48; IGLC2; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	38	125	30.4	0.00535500059239558	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	FLT4; GATA4; ISL1; NODAL;	GO:0010575~positive regulation of vascular endothelial growth factor production	4	28	14.2857142857143	0.00555263033109576	0.0912273701580734	1	1	0.999643926518233	0.999643926518233	0.76013748716987
down	FOXE1; GLI2; SHH; KRT27;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.00555263033109576	0.0912273701580734	1	1	0.999643926518233	0.999643926518233	0.76013748716987
down	RARB; SHH; OSR1; ALX4;	GO:0035116~embryonic hindlimb morphogenesis	4	28	14.2857142857143	0.00555263033109576	0.0912273701580734	1	1	0.999643926518233	0.999643926518233	0.76013748716987
down	CYP26A1; RBP4; TRIML2; RXRG; RARB;	GO:0032526~response to retinoic acid	5	46	10.8695652173913	0.00570720693369819	0.0924646790022076	1	1	0.999643926518233	0.999643926518233	0.770447165438612
down	KCNQ1; SHH; SIX1; PCDH15; LHX3;	GO:0048839~inner ear development	5	46	10.8695652173913	0.00570720693369819	0.0924646790022076	1	1	0.999643926518233	0.999643926518233	0.770447165438612
down	NPR1; NPPB; HAS2;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.00610138522845038	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	GATA4; NTRK2; NTRK1;	GO:0051896~regulation of protein kinase B signaling	3	14	21.4285714285714	0.00610138522845038	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	DLX1; HTRA3; RBPMS2; SFRP1; SOST;	GO:0030514~negative regulation of BMP signaling pathway	5	47	10.6382978723404	0.0061995446954819	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	HOXC11; HOXA11; SHH; FOXC2;	GO:0001656~metanephros development	4	29	13.7931034482759	0.00620762465943958	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	COL2A1; MMP13; MMP16; DLX5;	GO:0001958~endochondral ossification	4	29	13.7931034482759	0.00620762465943958	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	PITX3; EN2; EN1; SHH;	GO:0030901~midbrain development	4	29	13.7931034482759	0.00620762465943958	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	KIT; WT1; KITLG; HOXA10; HOXA11; GATA4; SFRP1;	GO:0008584~male gonad development	7	90	7.77777777777778	0.00639169848438348	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	NTRK1; GLI2; RARB; MIF; DPEP1; WT1; AZU1; PAX7; MT3; FLT4; ACTC1; NKX3-2; DHRS2; SHH; SFRP1; OSR1; BIRC7; HHIP; FAIM2; LHX3; NR2E1;	GO:0043066~negative regulation of apoptotic process	21	489	4.29447852760736	0.00647239768177754	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	KCNQ2; NALCN; KCNA7; CACNG6; KCNF1; KCNJ2; KCNJ12; KCNJ4;	GO:0034765~regulation of ion transmembrane transport	8	115	6.95652173913043	0.00681971048329721	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	CSF2; KIT; LIF; ISL1; IFNL1; IL20;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	6	69	8.69565217391304	0.00691158765250321	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	GUCA2B; CTRB2; PPARGC1A; CCK;	GO:0007586~digestion	4	30	13.3333333333333	0.00691194831747088	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	ADRA2C; HRH1; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.00691194831747088	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	MMP13; HAS2; PAPPA2; RARB;	GO:0060349~bone morphogenesis	4	30	13.3333333333333	0.00691194831747088	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	CLDN3; KRT16; MIF; DPEP1; NKX2-1; EPPK1; SHH; SFRP1;	GO:0030336~negative regulation of cell migration	8	116	6.89655172413793	0.00714997774070969	0.0953194175375755	1	1	0.999643926518233	0.999643926518233	0.794233818205666
down	RET; LIF; FOXC2;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.0072003900035067	0.0954460788533018	1	1	0.999643926518233	0.999643926518233	0.795289203383283
down	NR2E1; SIX1; SPOCK3; SIX2; RXRG;	GO:0048856~anatomical structure development	5	50	10	0.00785431559979921	0.10352609205837	1	1	0.999643926518233	0.999643926518233	0.86261462253499
down	EMX2; PROX1; NR2E1;	GO:0021542~dentate gyrus development	3	16	18.75	0.00840900895533681	0.1077924060044	1	1	0.999643926518233	0.999643926518233	0.89816300189519
down	TBX1; RARB; RXRG;	GO:0048384~retinoic acid receptor signaling pathway	3	16	18.75	0.00840900895533681	0.1077924060044	1	1	0.999643926518233	0.999643926518233	0.89816300189519
down	GLI2; RARB; FOXF2;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.00840900895533681	0.1077924060044	1	1	0.999643926518233	0.999643926518233	0.89816300189519
down	SYT3; RIMS4; SYT12;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.00840900895533681	0.1077924060044	1	1	0.999643926518233	0.999643926518233	0.89816300189519
down	SCN2B; KCNJ2; PKP2;	GO:0086002~cardiac muscle cell action potential involved in contraction	3	16	18.75	0.00840900895533681	0.1077924060044	1	1	0.999643926518233	0.999643926518233	0.89816300189519
down	FLT4; RET; NTRK1; EPHA8; KIT; NTRK2; SHC4; ROS1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	8	120	6.66666666666667	0.00859279875817087	0.109546445370561	1	1	0.999643926518233	0.999643926518233	0.91277825468479
down	VGF; GAL; PDX1; MAFA;	GO:0030073~insulin secretion	4	33	12.1212121212121	0.00933553567898571	0.115486819382835	1	1	0.999643926518233	0.999643926518233	0.962275472095693
down	CPA1; ALOX15; DPEP1;	GO:0006691~leukotriene metabolic process	3	17	17.6470588235294	0.00972948709744148	0.115486819382835	1	1	0.999643926518233	0.999643926518233	0.962275472095693
up	S100A8; S100A9; EDN3; LGALS3; EDN2; NCKAP1L; CXADR; CCL1; XCL2; CXCL2; CCL8; CCL22; CX3CL1; CCL21; CCL13; CCL16; CCL14; CCL17; CCL11; CCL18; CCL19; CXCL13; CCL23; CCL20; CCL2;	GO:0030593~neutrophil chemotaxis	25	76	32.8947368421053	0.00991617795736677	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	NKX2-8; ONECUT2; PDX1; PROX1; NODAL; RARB;	GO:0001889~liver development	6	75	8	0.00995404634042008	0.115536269214926	1	1	0.999643926518233	0.999643926518233	0.962687504921383
down	NTRK1; NTRK2; ATOH7; PROX1; PPARGC1A; HS3ST2;	GO:0007623~circadian rhythm	6	75	8	0.00995404634042008	0.115536269214926	1	1	0.999643926518233	0.999643926518233	0.962687504921383
down	TBX1; SHH; FOXA2; TBX4;	GO:0001708~cell fate specification	4	34	11.7647058823529	0.0102515147115947	0.118399919911636	1	1	0.999643926518233	0.999643926518233	0.986548416848995
down	BMPR1B; ISL1; ISL2;	GO:0031290~retinal ganglion cell axon guidance	3	18	16.6666666666667	0.0111637398220443	0.125888735786053	1	1	0.999643926518233	0.999643926518233	1
down	CSF2; DHRS2; BATF3;	GO:0043011~myeloid dendritic cell differentiation	3	18	16.6666666666667	0.0111637398220443	0.125888735786053	1	1	0.999643926518233	0.999643926518233	1
down	RBP4; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	3	18	16.6666666666667	0.0111637398220443	0.125888735786053	1	1	0.999643926518233	0.999643926518233	1
down	HOXB7; LHX1; SIX1;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.0111637398220443	0.125888735786053	1	1	0.999643926518233	0.999643926518233	1
down	BMPR1B; RBP4; MAB21L1; SMOC1;	GO:0001654~eye development	4	35	11.4285714285714	0.0112236849736387	0.125888735786053	1	1	0.999643926518233	0.999643926518233	1
down	CNGB1; ANO1; CALHM3; UNC80;	GO:0098655~cation transmembrane transport	4	35	11.4285714285714	0.0112236849736387	0.125888735786053	1	1	0.999643926518233	0.999643926518233	1
up	FCGR2B; AIF1; GULP1; IGHG2; IGHV1-2; IGHV3-33; IGHV3-30; IGLC2; IGHV3-7; IGHA2; IGHV3-20; IGHV3-74; IGHV3-21; IGHV2-5; TRDC; TRBC2; IGHV3-11; IGHV4-39; IGHV1-3; IGHV1-46; IGHV4-59; IGHV3-73; IGHV3-15; IGHG3; IGHV3-48; IGKC; IGHV4-34; IGLC3; IGHV5-51; IGHG4; IGHV1-18; IGHD; TRBC1; IGHV3-23;	GO:0006911~phagocytosis, engulfment	34	115	29.5652173913043	0.0112346680172777	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	BMPR1B; DLX1; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	4	36	11.1111111111111	0.0122532304268931	0.130120507307194	1	1	0.999643926518233	0.999643926518233	1
down	SHOX2; PRRX1; SHH; SFRP1;	GO:0045880~positive regulation of smoothened signaling pathway	4	36	11.1111111111111	0.0122532304268931	0.130120507307194	1	1	0.999643926518233	0.999643926518233	1
down	WT1; HOXD13; SHH;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.0127133704543434	0.130120507307194	1	1	0.999643926518233	0.999643926518233	1
down	BMPR1B; HOXA11; GDF6;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.0127133704543434	0.130120507307194	1	1	0.999643926518233	0.999643926518233	1
down	RET; LIF; IFNE;	GO:0033141~positive regulation of peptidyl-serine phosphorylation of STAT protein	3	19	15.7894736842105	0.0127133704543434	0.130120507307194	1	1	0.999643926518233	0.999643926518233	1
down	NPR1; NPPB; FOXC2;	GO:0097746~regulation of blood vessel diameter	3	19	15.7894736842105	0.0127133704543434	0.130120507307194	1	1	0.999643926518233	0.999643926518233	1
down	COL2A1; GLI2; OSR1; SIX2;	GO:0002062~chondrocyte differentiation	4	37	10.8108108108108	0.0133412700665519	0.132589581825743	1	1	0.999643926518233	0.999643926518233	1
down	SNCB; PACSIN1; ACTL8; ACTBL2;	GO:0048488~synaptic vesicle endocytosis	4	37	10.8108108108108	0.0133412700665519	0.132589581825743	1	1	0.999643926518233	0.999643926518233	1
down	GLI2; RARB; ADRA2C; SOX11; FOXG1; GDF6;	GO:0045666~positive regulation of neuron differentiation	6	81	7.40740740740741	0.0138449364658516	0.136865410062847	1	1	0.999643926518233	0.999643926518233	1
up	DEFB4A; CXCL13; HP; S100A8; S100A9; ANXA3; PRG2; IL10; SFTPD; RAG2; DEFB1; RAB1A; CCL20; LCN2; IRF8; COLEC12; GBP6; DEFB108B; NR1H4; S100A14; STAB1; SLAMF8; ADAMTS5; IGHV3-48; IGHG2; IGLC3; IGHG3; IGHV1-46; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGHV2-5; IGHD; IGHV3-74; IGHV1-18; IGHV3-7; GSDMC; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-23; HAMP; TRDC; IGHV3-20; IGKC; IGHV4-39; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	56	216	25.9259259259259	0.0138513965888876	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	BMPR1B; COL2A1; ALX1;	GO:0001502~cartilage condensation	3	20	15	0.0143796870983244	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	IGF2; CSF2; NODAL;	GO:0001892~embryonic placenta development	3	20	15	0.0143796870983244	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.0143796870983244	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	GLI2; RARB; NKX3-2;	GO:0032331~negative regulation of chondrocyte differentiation	3	20	15	0.0143796870983244	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	TBX1; LOX; FLT4;	GO:0048514~blood vessel morphogenesis	3	20	15	0.0143796870983244	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	VGF; KIT; KITLG; FOXL2;	GO:0001541~ovarian follicle development	4	38	10.5263157894737	0.0144888573915372	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	SCN2B; KCNQ1; KCNJ2; PKP2;	GO:0086091~regulation of heart rate by cardiac conduction	4	38	10.5263157894737	0.0144888573915372	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	FOXE1; ZIC2; CSF2; WT1; MT3; NKX2-1; LHX1; FOXG1; FOXL2; FOXF2; ZNF423; IFNL1; SFRP1; ESX1; DMBX1; PROX1; HMX1; SIX2; DPF1; SIX1; ALX1;	GO:0045892~negative regulation of transcription, DNA-templated	21	530	3.9622641509434	0.0144988919452907	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	CHP2; ALOX15; DPEP1; LCE1D; SYT12; SYT3;	GO:0071277~cellular response to calcium ion	6	82	7.31707317073171	0.0145833139659001	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	DPEP1; MT3; CERS1; KCNQ1; FGF21;	GO:0035690~cellular response to drug	5	59	8.47457627118644	0.0146067797842838	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	FOXG1; ISL1; ISL2; DISP3; NR2E1;	GO:0045665~negative regulation of neuron differentiation	5	59	8.47457627118644	0.0146067797842838	0.137966061687183	1	1	0.999643926518233	0.999643926518233	1
down	CLDN3; TBX1; FGF19; IGF2; NTRK1; MT3; FLT4; NTRK2; KNDC1;	GO:0001934~positive regulation of protein phosphorylation	9	161	5.59006211180124	0.0152850866346772	0.14058256179048	1	1	0.999643926518233	0.999643926518233	1
down	KCNK2; CCK; TH; HRH1; JPH3; SLC24A2;	GO:0007613~memory	6	83	7.2289156626506	0.0153486119666565	0.14058256179048	1	1	0.999643926518233	0.999643926518233	1
down	SOX11; CYP26C1; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.016163718798698	0.14058256179048	1	1	0.999643926518233	0.999643926518233	1
down	KNDC1; NR2E1; HECW1;	GO:0048814~regulation of dendrite morphogenesis	3	21	14.2857142857143	0.016163718798698	0.14058256179048	1	1	0.999643926518233	0.999643926518233	1
down	ADRA2C; ADRA1D; ADRA1B;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	3	21	14.2857142857143	0.016163718798698	0.14058256179048	1	1	0.999643926518233	0.999643926518233	1
down	CACNG3; CACNG4; SHISA9;	GO:2000311~regulation of AMPA receptor activity	3	21	14.2857142857143	0.016163718798698	0.14058256179048	1	1	0.999643926518233	0.999643926518233	1
up	ALOX15B; MT1A; MT1B; MT1G; MT1H; MT1X; PTK6; MT1M; PNPT1;	GO:0045926~negative regulation of growth	9	18	50	0.0165367109449549	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.0179047084707749	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	PITX3; TH; GAL;	GO:0035902~response to immobilization stress	3	22	13.6363636363636	0.0180662310429984	0.154390172246576	1	1	0.999643926518233	0.999643926518233	1
down	CCL24; FTCD; KRT16; CTNNA2; KRT76; CECR2; KRT84; PACSIN1;	GO:0007010~cytoskeleton organization	8	139	5.75539568345324	0.0185577501211311	0.157542742117816	1	1	0.999643926518233	0.999643926518233	1
down	KIT; SFRP1; SALL4; FOXD3; NR2E1;	GO:0035019~somatic stem cell population maintenance	5	63	7.93650793650794	0.0185701903482209	0.157542742117816	1	1	0.999643926518233	0.999643926518233	1
up	APOA1; APOC3; APOB; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	6	9	66.6666666666667	0.0192396135163669	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	TNFRSF13B; CXCL13; LILRA1; TRPA1; ADGRL2; TSPAN12; F2; IFNG; IL2RA; CD3D; ADRB2; CD3G; CCL2; EDN3; EDN2; EDNRB; KLRC1; BDKRB2; CCKBR; ADCYAP1R1; GLP1R; GCGR; SCTR; CXCR3; CCR5; ADGRE1; ADGRF1; ADGRG6; ADGRF5; ADGRF2; LILRB2; CLEC1A; GLMN; ADGRE3; CBLC; CLEC4A; TRBV24-1; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV3-1; TRBV2; TRBV28; TRBV6-2; TRBV7-2; TRBV4-1; TRBV7-6; TRBV29-1; TRBV30; TRBV4-2; TRBV20-1; TRBV6-5; TRBV12-4; TRBV5-6; TRBV23-1; TRBV5-4; TRBV9; ANXA1; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	66	268	24.6268656716418	0.0196185874344212	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	FOXG1; SHH; DMRTA2;	GO:0002052~positive regulation of neuroblast proliferation	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	TBX1; SHOX2; PRRX1;	GO:0002053~positive regulation of mesenchymal cell proliferation	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	DSCAM; LHX1; SDK1;	GO:0010842~retina layer formation	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	CYP7B1; CYP26A1; CYP26C1;	GO:0016125~sterol metabolic process	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	CCK; TH; TCF15;	GO:0042755~eating behavior	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	NOTO; MCIDAS; CCDC40;	GO:0044458~motile cilium assembly	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	GLI2; HOXA11; DMBX1;	GO:0048589~developmental growth	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	TBX1; PRRX1; FOXC2;	GO:0048844~artery morphogenesis	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	PRRX1; PROX1; IGF2BP1;	GO:0097150~neuronal stem cell population maintenance	3	23	13.0434782608696	0.020087740627462	0.160176163434621	1	1	0.999643926518233	0.999643926518233	1
down	ADAMTS3; MMP1; MMP13; MMP16;	GO:0030574~collagen catabolic process	4	43	9.30232558139535	0.0211522659213821	0.166717014846569	1	1	0.999643926518233	0.999643926518233	1
down	KCNJ2; KCNJ12; SLC12A5; KCNJ4;	GO:1990573~potassium ion import across plasma membrane	4	43	9.30232558139535	0.0211522659213821	0.166717014846569	1	1	0.999643926518233	0.999643926518233	1
down	NKX2-1; SFRP1; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	3	24	12.5	0.022228529908966	0.17228956902863	1	1	0.999643926518233	0.999643926518233	1
down	NPR1; GUCA2B; NPPB;	GO:0019934~cGMP-mediated signaling	3	24	12.5	0.022228529908966	0.17228956902863	1	1	0.999643926518233	0.999643926518233	1
down	ONECUT2; FOXA2; PDX1;	GO:0031018~endocrine pancreas development	3	24	12.5	0.022228529908966	0.17228956902863	1	1	0.999643926518233	0.999643926518233	1
down	TBX1; GLI2; SIX1;	GO:0090103~cochlea morphogenesis	3	24	12.5	0.022228529908966	0.17228956902863	1	1	0.999643926518233	0.999643926518233	1
down	FOXE1; TBX1; SHH; SIX1;	GO:0048538~thymus development	4	44	9.09090909090909	0.0226755703347383	0.175172535069353	1	1	0.999643926518233	0.999643926518233	1
down	IGF2; IL5; CCK; MIF; LIF; KITLG;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	6	92	6.52173913043478	0.0235179310827175	0.178889029275777	1	1	0.999643926518233	0.999643926518233	1
up	IL18RAP; IL12A; IL12B; IL18;	GO:0035744~T-helper 1 cell cytokine production	4	4	100	0.0235884015710969	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	SOX11; HLF; VAX1; DMRTA2;	GO:0035914~skeletal muscle cell differentiation	4	45	8.88888888888889	0.02426395271968	0.178889029275777	1	1	0.999643926518233	0.999643926518233	1
down	NTRK2; SYT12; NR2E1; SLC24A2;	GO:0060291~long-term synaptic potentiation	4	45	8.88888888888889	0.02426395271968	0.178889029275777	1	1	0.999643926518233	0.999643926518233	1
down	KCNJ4; KCNJ2; KCNJ12; KCNF1; KCNS2;	GO:0006813~potassium ion transport	5	68	7.35294117647059	0.0244412878211837	0.179312970084345	1	1	0.999643926518233	0.999643926518233	1
down	TCF15; FOXC2; HES7; DLL3;	GO:0001756~somitogenesis	4	46	8.69565217391304	0.0259179423702662	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	TBX1; SOX11; ISL1; SIX1;	GO:0003151~outflow tract morphogenesis	4	46	8.69565217391304	0.0259179423702662	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	NKX2-1; SHH; PPARGC1A; VAX2;	GO:0030900~forebrain development	4	46	8.69565217391304	0.0259179423702662	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	DSCAM; MIF; APLN;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.0268679861837563	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
up	EIF6; RRP15; WDR12; MRPL1; SNU13; RPF1; RSL1D1; MAK16;	GO:0000470~maturation of LSU-rRNA	8	17	47.0588235294118	0.0297924379257871	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	ELFN1; SNCB; CTNND2; PCDHGC5;	GO:0050808~synapse organization	4	49	8.16326530612245	0.0312778982672023	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	CCL24; FLT4; PRKD1; PROX1; CCL26;	GO:0001938~positive regulation of endothelial cell proliferation	5	73	6.84931506849315	0.0313880587940408	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	TBX1; RARB; ISL1;	GO:0003148~outflow tract septum morphogenesis	3	28	10.7142857142857	0.0319826749071824	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	CNGB1; ATP13A5; ANO1;	GO:0006812~cation transport	3	28	10.7142857142857	0.0319826749071824	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	ADRA1D; ADRA1B; ADRA2C;	GO:0007610~behavior	3	28	10.7142857142857	0.0319826749071824	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	KIT; PDX1; ALX4;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.0319826749071824	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
up	CCL22; DEFB4A; CCL16; PIK3C2G; RNASE2; CCL2; CXCL2; CCL1; FPR3; CCL11; CCR6; NCKAP1L; CCL23; CCL18; DEFB1; CX3CL1; CCL20; CCL8; AIMP1; PLD1; RALBP1; ECSCR; CMTM8; CCL17; CCL13; RARRES2; PLGRKT; CXCR3; CCR8; XCR1; CCR2; ACKR2; CCR5;	GO:0006935~chemotaxis	33	122	27.0491803278689	0.0321425132639509	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	FMO2; CYP2F1; CYP2J2; CYP2C19; CYP2A7; CYP2A6; CYP2C9; CYP2G1P; CYP2C18;	GO:0006082~organic acid metabolic process	9	21	42.8571428571429	0.032836953567381	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	CYP2C9; CYP2C19; CYP2J2; CYP4A11; CYP2G1P; CYP2A7; CYP2F1; CYP2C18; CYP2A6;	GO:0019373~epoxygenase P450 pathway	9	21	42.8571428571429	0.032836953567381	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	TMED2; KIF13A; CTAGE4; CTAGE1; CTAGE8; CTAGE3P; CTAGE6;	GO:0035459~vesicle cargo loading	7	14	50	0.0331302535888516	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	CCL2; LGALS3; EDN2; EDNRB; SFTPD; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	7	14	50	0.0331302535888516	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	HOXD9; HOXD10; SIX1; POPDC3;	GO:0007519~skeletal muscle tissue development	4	50	8	0.0331983495791257	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	HRH1; JPH3; RIMS4; VGF;	GO:0048167~regulation of synaptic plasticity	4	50	8	0.0331983495791257	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
up	CCL21; CCL22; WNT9B; EREG; CCL16; SIGLEC6; CXCL13; POMC; C1QA; WNT1; PGR; S100A9; BMP3; EDN3; ADCYAP1; NTF3; FGFR3; GJB2; TNFSF9; FASLG; CCR5; AFDN; CCL23; CCL18; IL2; CX3CL1; CCL20; CCL8; PCDH1; AIMP1; GRAP; IL18; IL17A; LILRB2; CCL17; TFAP2C; PCSK5; FGF14; SH3KBP1; FCRL2; TBX5; CCL13; FGF20; IL26; STAB1; SIRPG; GPR101; ADRA2B; ADRB3; PTH; DRD1; ADRB2; PANX1; ADRA2A; FGFBP1; ADRA1A;	GO:0007267~cell-cell signaling	56	230	24.3478260869565	0.0344290229752066	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	GBX2; SHH; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	3	29	10.3448275862069	0.0347168174495669	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	FBLL1; ST8SIA6; PLPP4;	GO:0001835~blastocyst hatching	3	29	10.3448275862069	0.0347168174495669	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	SCIN; SYT3; SYT12;	GO:0017156~calcium-ion regulated exocytosis	3	29	10.3448275862069	0.0347168174495669	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	IL5; KIT; IFNL1;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	3	29	10.3448275862069	0.0347168174495669	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	NKX2-1; NTRK2; SHH;	GO:0048709~oligodendrocyte differentiation	3	29	10.3448275862069	0.0347168174495669	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	CCL24; CDC42EP2; ALOX15; CCL26;	GO:0030838~positive regulation of actin filament polymerization	4	51	7.84313725490196	0.0351861169500617	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
up	S100A8; S100A9; SELE; CCR6; CX3CL1; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	6	11	54.5454545454545	0.0361904184750524	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	IFNG; PRNP; IL12A; IL12B; NCKAP1L; IL36RN;	GO:0032700~negative regulation of interleukin-17 production	6	11	54.5454545454545	0.0361904184750524	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	JUP; DSP; DSC2; DLG1; RYR2; CTNNA3;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	6	11	54.5454545454545	0.0361904184750524	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0373444349933267	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	TLCD2; TRIAP1; TLCD1; PRELID1;	GO:0097035~regulation of membrane lipid distribution	4	5	80	0.0373444349933267	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	TRIAP1; DBI; CETP; PRELID1;	GO:2001140~positive regulation of phospholipid transport	4	5	80	0.0373444349933267	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	CASQ2; CLIC2; CALM1; CALM2; HRC; AKAP6; CAMK2D; METTL21C;	GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	8	18	44.4444444444444	0.0373741220067556	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	CCL24; VGF; REG1A; CCK; RET; CGB7; KIT; RARB; GRIA2; GNGT1; TNFAIP6; IL1RL1; INSL4; PRKD1; CD200R1; CASKIN1; FGF11; HHIP; DPYSL5; RETNLB; TRIM55; FGF21; APLN; CTNND2; CCL26; KCNIP3; GABRD; PLPP4; PLPPR5; NPR1; SCUBE2; GABRA1;	GO:0007165~signal transduction	32	989	3.2355915065723	0.0398284279807205	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	KIT; EPHA8; PRKD1;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	3	31	9.67741935483871	0.0405344259297038	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	CDK5R2; PROX1; CCNYL2;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	3	31	9.67741935483871	0.0405344259297038	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	FLT4; PRKD1; PROX1; FOXC2;	GO:0010595~positive regulation of endothelial cell migration	4	54	7.40740740740741	0.0415546340595441	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	TRABD2B; CDC42EP2; MMP1; CCK;	GO:0031334~positive regulation of protein-containing complex assembly	4	54	7.40740740740741	0.0415546340595441	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
up	MPHOSPH10; DKC1; RPP40; RPS17; SNU13; NOP14; RPP38; FRG1; UTP15; EMG1; EXOSC8; RRP36; MPHOSPH6; UTP14A; WDR12; NOL11; ISG20L2; UTP3; DDX21; DCAF13; IMP3; LYAR; UTP6; WDR3; PA2G4; UTP11; SBDS; EXOSC1; POP5; DDX10; RPF1; EBNA1BP2; POP4; MRTO4; ESF1; PIH1D2;	GO:0006364~rRNA processing	36	139	25.8992805755396	0.0416195684750077	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	GGCT; GGT5; GCLC; GGT6; CHAC2; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	7	15	46.6666666666667	0.0422990679402248	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	GRIK2; GRM7; NR2E1;	GO:0001662~behavioral fear response	3	32	9.375	0.0436157381926247	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	ONECUT2; NR2E1; GATA5; GATA4;	GO:0045165~cell fate commitment	4	55	7.27272727272727	0.0438126995856598	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	COL2A1; GNB3; LOX; LHX1; DUX4L9; SHC4; PROX1; SHH;	GO:0010468~regulation of gene expression	8	166	4.81927710843374	0.0440061923985089	0.186663466483777	1	1	0.999643926518233	0.999643926518233	1
down	TFPI; SFRP1; HAS2; CCL26; CCL24;	GO:0071347~cellular response to interleukin-1	5	81	6.17283950617284	0.0448494034128705	0.187852169052472	1	1	0.999643926518233	0.999643926518233	1
down	SOX1; CCK; NKX2-1; CDK5R2; NTRK2; VAX1;	GO:0001764~neuron migration	6	109	5.5045871559633	0.0459371460324072	0.192063372210763	1	1	0.999643926518233	0.999643926518233	1
down	DLX1; POSTN; SFRP1; PPARGC1A;	GO:0071560~cellular response to transforming growth factor beta stimulus	4	56	7.14285714285714	0.046138317651979	0.192559382973286	1	1	0.999643926518233	0.999643926518233	1
down	TH; KCNQ1; KCNJ12;	GO:0008016~regulation of heart contraction	3	33	9.09090909090909	0.0468103962406661	0.194667833207618	1	1	0.999643926518233	0.999643926518233	1
down	SHOX2; NTRK2; MAP6;	GO:0050772~positive regulation of axonogenesis	3	33	9.09090909090909	0.0468103962406661	0.194667833207618	1	1	0.999643926518233	0.999643926518233	1
up	FABP12; APOC3; APOB; LPL; FABP1; FABP2; FABP5; LIPE; MGLL;	GO:0019433~triglyceride catabolic process	9	23	39.1304347826087	0.048429583772409	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
up	IL2RA; IGF1; IGFBP2; CD24; IL12B; IL2; IL18; HHLA2; TNFSF9;	GO:0042104~positive regulation of activated T cell proliferation	9	23	39.1304347826087	0.048429583772409	0.999999999999998	1	1	0.999999999999998	0.999999999999998	1
down	NKX2-1; PLA2G4E; PLPP4; PLPPR5;	GO:0006644~phospholipid metabolic process	4	57	7.01754385964912	0.0485313716244054	0.20020720518394	1	1	0.999643926518233	0.999643926518233	1
down	KCNK2; GATA4; POSTN; SOST;	GO:0009612~response to mechanical stimulus	4	57	7.01754385964912	0.0485313716244054	0.20020720518394	1	1	0.999643926518233	0.999643926518233	1
down	STC2; KCNK2; MT3; GNGT1; SFRP1; PPARGC1A;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.0492216575148566	0.20020720518394	1	1	0.999643926518233	0.999643926518233	1
